ArticleFrontiers in cell and developmental biology2024

Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.

Annabelle Darle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.